Physician
Javier a Saenz MD PA
Javier a Saenz MD PA was paid $888K by Medicaid between Jan 2018 and Dec 2024, across 146 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoJAVIER A SAENZ MD PA
LA JOYA, TX 78560
LA JOYA, TX 78560
33aNPI1508884412assigned 07/18/2006
33bProvider typeFamily Medicine Physician
28Total paid$888K
24GClaims346,114
24DCodes billed146
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#109 of 1,204
Median peer was paid$31K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,031 | $43K | |
| 2019 | 34,104 | $34K | |
| 2020 | 40,208 | $81K | |
| 2021 | 73,772 | $248K | |
| 2022 | 60,167 | $233K | |
| 2023 | 59,264 | $154K | |
| 2024incomplete | 31,568 | $96K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 16,013 | 12,505 | $366K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 5,194 | 4,511 | $154K |
| 99000 | 3.9% | 6,224 | 5,732 | $35K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.2% | 5,206 | 3,271 | $29K |
| 92081 | 2.3% | 2,053 | 1,946 | $20K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.2% | 2,261 | 1,115 | $19K |
| 99490 | Ccm add 20min | 2.1% | 3,518 | 3,510 | $18K |
| 99442 | 1.9% | 839 | 740 | $17K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 568 | 534 | $17K |
| 92587 | 1.9% | 2,125 | 2,021 | $17K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.8% | 272 | 255 | $16K |
| 99441 | 1.7% | 1,269 | 1,103 | $15K |
134 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 1.6% | 5,147 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 6,286 | $14K |
| 99444 | 1.4% | 216 | $12K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.4% | 1,870 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 1,209 | $11K |
| 99443 | 1.2% | 276 | $11K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 236 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,832 | $8K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 108 | $6K |
| 81000 | <1% | 5,823 | $6K | |
| 96116 | <1% | 1,016 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 266 | $5K |
| 90674 | <1% | 801 | $4K | |
| 80061 | Lipid panel | <1% | 3,416 | $4K |
| 82044 | <1% | 3,091 | $4K | |
| 99497 | <1% | 922 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 936 | $3K |
| 84439 | <1% | 2,730 | $3K | |
| 83721 | <1% | 3,381 | $3K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,125 | $3K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 908 | $3K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 44 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 448 | $3K |
| 90686 | <1% | 854 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,212 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 15 | $995.10 |
| 90661 | <1% | 73 | $991.80 | |
| 90756 | <1% | 166 | $924.72 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 3,286 | $819.51 |
| 95923 | <1% | 46 | $792.08 | |
| 87088 | <1% | 1,125 | $708.38 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 169 | $683.07 |
| 82565 | <1% | 2,179 | $521.93 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 2,376 | $518.04 |
| 94010 | <1% | 40 | $446.86 | |
| 81001 | <1% | 342 | $434.84 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,369 | $434.09 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 788 | $403.44 |
| 96160 | <1% | 539 | $403.23 | |
| 0031A | <1% | 34 | $384.85 | |
| 99406 | <1% | 1,124 | $363.25 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 580 | $346.31 |
| 0012A | <1% | 40 | $343.23 | |
| 82607 | <1% | 752 | $286.56 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 1,612 | $278.91 |
| 0011A | <1% | 46 | $187.36 | |
| 97169 | <1% | 42 | $185.00 | |
| 80076 | <1% | 458 | $182.69 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 412 | $172.98 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,219 | $167.43 |
| 93922 | <1% | 15 | $157.83 | |
| 82746 | <1% | 412 | $137.25 | |
| 87807 | <1% | 19 | $132.00 | |
| 93000 | <1% | 25 | $117.97 | |
| 99496 | <1% | 261 | $117.46 | |
| 93923 | <1% | 15 | $104.07 | |
| 90461 | <1% | 32 | $89.93 | |
| 82550 | <1% | 276 | $89.08 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 1,214 | $82.31 |
| 90688 | <1% | 44 | $80.00 | |
| G0008 | Administration of influenza virus vaccine | <1% | 827 | $67.34 |
| 87081 | <1% | 86 | $54.96 | |
| 82570 | <1% | 18 | $34.80 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,102 | $29.47 |
| 85651 | <1% | 76 | $25.46 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,742 | $4.80 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,602 | $0.14 |
| 91301 | <1% | 85 | $0.05 | |
| 91303 | <1% | 35 | $0.03 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 68 | $0.01 |
| 1036F | 0% | 21,168 | $0.00 | |
| 2010F | 0% | 13,762 | $0.00 | |
| 2001F | 0% | 13,645 | $0.00 | |
| 3074F | 0% | 9,886 | $0.00 | |
| 3044F | 0% | 2,639 | $0.00 | |
| 0509F | 0% | 193 | $0.00 | |
| 1110F | 0% | 81 | $0.00 | |
| 3008F | 0% | 13,578 | $0.00 | |
| 4086F | 0% | 3,656 | $0.00 | |
| 1101F | 0% | 923 | $0.00 | |
| 1170F | 0% | 1,182 | $0.00 | |
| 3075F | 0% | 1,992 | $0.00 | |
| 1111F | 0% | 246 | $0.00 | |
| 1126F | 0% | 368 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 8,917 | $0.00 |
| G8450 | Beta-blocker therapy prescribed | 0% | 1,594 | $0.00 |
| G0513 | Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service) | 0% | 12 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 24,406 | $0.00 |
| 3079F | 0% | 1,444 | $0.00 | |
| 84153 | 0% | 27 | $0.00 | |
| 3017F | 0% | 199 | $0.00 | |
| 1034F | 0% | 462 | $0.00 | |
| 1123F | 0% | 265 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 312 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 226 | $0.00 |
| G9716 | Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason | 0% | 20 | $0.00 |
| 1125F | 0% | 148 | $0.00 | |
| G8422 | Bmi not documented, documentation the patient is not eligible for bmi calculation | 0% | 227 | $0.00 |
| 77081 | 0% | 13 | $0.00 | |
| 3080F | 0% | 36 | $0.00 | |
| 90651 | 0% | 42 | $0.00 | |
| 90656 | 0% | 20 | $0.00 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | 0% | 13 | $0.00 |
| 97802 | 0% | 17 | $0.00 | |
| 3061F | 0% | 29 | $0.00 | |
| 90619 | 0% | 12 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 3,621 | $0.00 |
| 4004F | 0% | 329 | $0.00 | |
| 3078F | 0% | 10,878 | $0.00 | |
| 1160F | 0% | 10,050 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 23,604 | $0.00 |
| 1090F | 0% | 1,063 | $0.00 | |
| 1159F | 0% | 10,082 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 16,806 | $0.00 |
| G8539 | Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment | 0% | 933 | $0.00 |
| 4013F | 0% | 2,275 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 2,470 | $0.00 |
| G8935 | Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 2,943 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 9,234 | $0.00 |
| 3725F | 0% | 1,889 | $0.00 | |
| 3045F | 0% | 207 | $0.00 | |
| 3288F | 0% | 1,306 | $0.00 | |
| 4040F | 0% | 144 | $0.00 | |
| 2022F | 0% | 42 | $0.00 | |
| 0521F | 0% | 140 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 629 | $0.00 |
| 77080 | 0% | 13 | $0.00 | |
| 3077F | 0% | 74 | $0.00 | |
| G0246 | Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education | 0% | 27 | $0.00 |
| G9730 | Patient refused to participate | 0% | 58 | $0.00 |
| 1158F | 0% | 15 | $0.00 | |
| 90734 | 0% | 16 | $0.00 | |
| 99354 | 0% | 12 | $0.00 | |
| 99397 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSAENZ, JAVIER (PHYSICIAN)